MEREO BIOPHARMA GROUP PLC

Insiders Mereo BioPharma Group plc

Equities

MREO

US5894921072

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-30 pm EDT			5-day change	1st Jan Change
3.05 ^USD	+10.51%		+9.71%	+32.03%

Apr. 30	European Equities Traded in the US as American Depositary Receipts Decline	MT
Apr. 26	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mereo BioPharma Group plc Announces Board Changes	22-10-28	CI
Mereo BioPharma Group plc Announces Board Changes	22-05-17	CI
Mereo BioPharma Group plc Announces Appointment of Anne Hyland to Board of Directors	22-03-01	CI
Mereo Biopharma Announces Board Changes	21-09-20	CI
Mereo Biopharma Group plc Announces the Appointment of Suba Krishnan, M.D. as Senior Vice President of Clinical Development, Effective December 7, 2020	20-11-23	CI
Mereo Biopharma Group plc Appoints Heidi Petersen as Senior Vice President, Regulatory Affairs	20-10-20	CI
Mereo BioPharma Group plc Announces Changes to Board of Directors	20-09-28	CI
Mereo Biopharma Group plc Appoints Michael Wyzga as Interim Chief Financial Officer	20-08-03	CI
Mereo Biopharma Group plc Cease Michael Wyzga as Member of Audit and Risk Committee	20-08-03	CI
Richard Jones Announces Step Down from the Board of Mereo BioPharma Group plc	20-06-30	CI
Mereo BioPharma Group plc Appoints John Lewicki, as Chief Scientific Officer and Ann Kapoun as SVP of Translational Research and Development	20-06-30	CI
Mereo BioPharma Group plc Appoints Arun Mistry as Therapeutic Area Head, Setrusumab	19-09-17	CI
Mereo BioPharma Group plc Appoints Richard Francis as Head of Pharmaceutical Development, Effective August 1, 2019	19-07-16	CI
Mereo BioPharma Group plc Announces Board Appointments	19-04-23	CI
Mereo Biopharma Group plc Announces Board Changes	19-02-11	CI
Mereo BioPharma Group plc Announces Board Appointments	18-12-05	CI
Mereo BioPharma Group plc Appoints Wills Hughes-Wilson as Head of Patient Access and Commercial Planning	18-02-26	CI
Mereo Biopharma Group plc Appoints Richard CM Jones as Chief Financial Officer and Board of Director	16-11-07	CI
Richard Bungay to Leave Mereo BioPharma Group plc as Chief Financial Officer and Chief Operating Officer in April 2017	16-10-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer